Curcumin as a Stabilizer of Macrophage Polarization during Plasmodium Infection

• Published in: Pharmaceutics 2023-10, Vol.15 (10), p.2505
• Main Authors: Cordeiro, Maria Clara C., Tomé, Fernanda D., Arruda, Felipe S., da Fonseca, Simone Gonçalves, Nagib, Patrícia R. A., Celes, Mara R. N.
• Format: Article
• Language: English
• Subjects: Antigens; arginase; Blood; curcumin; Cytokines; Enzymes; FDA approval; Genotype & phenotype; Infections; iNOS; Malaria; Pathogens; phagocytosis; RAW 264.7 cells; Yeast
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics15102505

Malaria is a parasitic infection responsible for high morbidity and mortality rates worldwide. During the disease, phagocytosis of infected red blood cells by the macrophages induces the production of reactive oxygen (ROS) and nitrogen species (RNS), culminating in parasite death. Curcumin (CUR) is a bioactive compound that has been demonstrated to reduce the production of pro-inflammatory cytokines and chemokines produced by macrophages but to reduce parasitemia in infected mice. Hence, the main purpose of this study is to investigate whether curcumin may interfere with macrophage function and polarization after Plasmodium berghei infection in vitro. In our findings, non-polarized macrophage (M0), classically activated (M1), and alternatively activated (M2) phenotypes showed significantly increased phagocytosis of infected red blood cells (iRBCs) when compared to phagocytosis of uninfected red blood cells (RBCs) 3 h after infection. After 24 h, M1 macrophages exposed to RBCs + CUR showed greater elimination capacity when compared to macrophages exposed to iRBCs + CUR, suggesting the interference of curcumin with the microbicidal activity. Additionally, curcumin increased the phagocytic activity of macrophages when used in non-inflammatory conditions (M0) and reduced the inducible nitric oxide synthase (iNOS) and arginase activities in all macrophage phenotypes infected (M0, M1, and M2), suggesting interference in arginine availability by curcumin and balance promotion in macrophage polarization in neutral phenotype (M0). These results support the view of curcumin treatment in malaria as an adjuvant, promoting a balance between pro- and anti-inflammatory responses for a better clinical outcome.